Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
A triple-agonist research peptide (GIP / GLP-1 / glucagon) studied in the metabolic field
Keep the vial or pen at least 2-3 inches from the back wall
Clinical trials are testing them for heart disease, sleep apnea, liver disease, even addiction
The 8mg dose achieved 21.1% weight loss (matching Zepbounds efficacy) with lower side effects: 24% nausea versus 28% at 12mg, 8.4% discontinuation versus 11.2%
Synthetic forms in medications break down more slowly to help reduce overall appetite and food intake
In mouse and rat models, measuring levels of active GLP-1 provides valuable insight into metabolic regulation, gut hormone signaling, and the mechanisms underlying glucose tolerance and energy balance
US$ 25.17
US$ 29.61
US$ 21.59
US$ 27.70
US$ 24.97
